Showing results (91-100 of 200) with videos related to
Sort By:
Pageof 20
European Journal of Immunology|June 12, 2013
IL-15 modulates the balance between Bcl-2 and Bim via a Jak3/1-PI3K-Akt-ERK pathway to promote CD8αα+ intestinal intraepithelial lymphocyte survivalYein-Gei Lai, Mau-Sheng Hou, Albert Lo, et al.World Journal of Clinical Cases|July 10, 2024
Exploring the potential mechanism of WuFuYin against hypertrophic scar using network pharmacology and molecular dockingShu-Yang Zhang, Song-Xue Guo, Lei-Lei Chen, et al.Cancer Research|March 4, 2010
Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion proteinDapeng Zhang, Bohua Li, Jingping Shi, et al.Scientific Reports|November 23, 2017
Sublethal effects of imidacloprid on targeting muscle and ribosomal protein related genes in the honey bee Apis mellifera LYan-Yan Wu, Qi-Hua Luo, Chun-Sheng Hou, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in miceHuafeng Wei, Suhui Wang, Dapeng Zhang, et al.Pharmaceuticals (Basel, Switzerland)|May 27, 2026
A Three-Arm, Tiered Comparability Strategy Bridging Post-Approval Process Changes for an Omalizumab Biosimilar (CMAB007)Chenguang Wang, Chaoxin Zhou, Sheng Hou, et al.Journal of Pharmaceutical and Biomedical Analysis|May 9, 2024
Development of a reliable cell-based reporter gene assay to measure the bioactivity of anti-HER2 therapeutic antibodiesXiang Zhao, Weizhu Qian, Sheng Hou, et al.European Journal of Pharmacology|February 9, 2011
A humanized anti-osteopontin antibody protects from Concanavalin A induced-liver injury in miceKexing Fan, Bo Zhang, Haiou Yang, et al.Biochemical and Biophysical Research Communications|April 17, 2010
Development and characterization of a novel anti-IgE monoclonal antibodyWeizhu Qian, Xunmin Zhang, Bohua Li, et al.Drug Design, Development and Therapy|March 19, 2019
Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression systemQing An, Yingxin Zheng, Yirong Zhao, et al.Pageof 20